Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244486 · ClinicalTrials.gov registry record · NA
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
A NA study of Erectile Dysfunction Following Radical Prostatectomy, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05244486 is a NA study of Erectile Dysfunction Following Radical Prostatectomy that is actively recruiting participants, run by Charitable Union for the Research and Education of Peyronie's Disease. The registered enrollment target is 200 participants, above the 166-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05244486, a NA study of Erectile Dysfunction Following Radical Prostatectomy, is actively recruiting participants, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The primary outcome will be changes in the IIEF-EFD scores between groups at 6 months. Secondary outcomes include differences in questionnaire outcomes at 3, 6, and 9 months.
Conditions Studied
Interventions
- DEVICE RestoreX 1-6 months (randomized phase)
- DEVICE RestoreX 6-9 months (open label phase)
Study Locations (1)
Utah
- The Male Fertility and Peyronie's Clinic - Orem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-03-12 |
| Est. Completion | 2030-09-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05244486
The ClinicalTrials.gov registry entry for NCT05244486 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 166-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (20% higher). The listed sponsor is Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction Following Radical Prostatectomy appearing as the primary indexed condition, and to 2 interventions - of which RestoreX 1-6 months (randomized phase) is the first listed.
NCT05244486 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05244486 about?
NCT05244486 is a clinical study titled "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy". Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The...
What is the current status of trial NCT05244486?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-03-12. Estimated completion is 2030-09-14.
What conditions does trial NCT05244486 study?
This clinical trial studies the following conditions: Erectile Dysfunction Following Radical Prostatectomy.
What interventions are being tested in trial NCT05244486?
The interventions under investigation include: RestoreX 1-6 months (randomized phase) (DEVICE), RestoreX 6-9 months (open label phase) (DEVICE).
Who is sponsoring clinical trial NCT05244486?
This trial is sponsored by Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05244486 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction Following Radical Prostatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
RECRUITING · NA
-
Low Intensity Shockwave Therapy for Erectile Dysfunction
ACTIVE NOT RECRUITING · NA
-
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.